Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:26 pm Unchanged |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
LAV Biosciences Fund V L.P. | 25,406,680 5.300% |
0 (Unchanged) |
Filing History |
| 2024-02-13 5:23 pm Purchase |
2023-12-31 | 13G | Burning Rock Biotech Limited BNR |
LAV Biosciences Fund V L.P. | 438,421 5.100% |
438,421 (New Position) |
Filing History |
| 2024-02-13 5:21 pm Unchanged |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
LAV Biosciences Fund V L.P. | 2,901,566 4.700% |
0 (Unchanged) |
Filing History |
| 2023-02-06 2:45 pm Sale |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
LAV Biosciences Fund V L.P. | 2,901,566 6.100% |
-63,304 (-2.14%) |
Filing History |
| 2022-12-29 2:57 pm Sale |
2022-12-27 | 13G | Terns Pharmaceuticals, Inc. TERN |
LAV Biosciences Fund V L.P. | 2,964,870 6.180% |
-1,816,696 (-37.99%) |
Filing History |
| 2022-02-09 12:29 pm Purchase |
2021-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
LAV Biosciences Fund V L.P. | 4,781,566 18.900% |
4,781,566 (New Position) |
Filing History |
| 2022-02-09 12:17 pm Purchase |
2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
LAV Biosciences Fund V L.P. | 25,406,680 7.800% |
25,406,680 (New Position) |
Filing History |